DR Congo has begun testing an Ebola vaccine among health workers at the center of the outbreak. The program targets personnel facing the highest exposure risk.
9:51 PMAl Jazeera7 stories from 3 sources
Ebola outbreak drives urgent vaccination and preparedness test
Day’s Recap
Supporting Articles
DR Congo is offering an Ebola vaccine to 50,000 frontline workers as deaths from the outbreak rise. About 20,000 of them will participate in a one-year clinical trial testing a vaccine against a different Ebola strain.
8:36 PMAl Jazeera
Researchers found a molecular warning sign of inflammatory bowel disease that can persist even when patients appear healthy and are in remission. Analysis of about 900 gut biopsies and patient-derived mini-intestines showed that intestinal cells can remain unusually primed to die, creating a lingering defect linked to future flare-ups.
11:41 PMScienceDaily
Scientists identified the genetic cause of the AnWj blood group antigen, resolving a mystery first documented in 1972 and establishing the MAL blood group system. The finding should help laboratories identify rare AnWj-negative patients and donors and reduce the risk of dangerous transfusion reactions.
6:14 AMScienceDaily9:51 PMAl Jazeera
DR Congo begins Ebola vaccination trials for frontline health workers
Summary
DR Congo has begun testing an Ebola vaccine among health workers at the center of the outbreak. The program targets personnel facing the highest exposure risk.
The immediate priority is protecting health workers, who can amplify transmission inside clinics and hospitals.
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Protecting health workers can preserve the medical response and reduce transmission in healthcare settings.
8:36 PMAl Jazeera
DR Congo rolls out Ebola vaccine for health workers as death toll rises
Summary
DR Congo is offering an Ebola vaccine to 50,000 frontline workers as deaths from the outbreak rise. About 20,000 of them will participate in a one-year clinical trial testing a vaccine against a different Ebola strain.
The rising death toll is forcing a large-scale intervention before the vaccine’s effectiveness against this
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The campaign combines emergency protection with research that could shape the broader response to the outbreak.
11:41 PMScienceDaily
Hidden gut defect that may explain why IBD keeps coming back
Summary
Researchers found a molecular warning sign of inflammatory bowel disease that can persist even when patients appear healthy and are in remission. Analysis of about 900 gut biopsies and patient-derived mini-intestines showed that intestinal cells can remain unusually primed to die, creating a lingering defect linked to future flare-ups.
The key shift is that remission may conceal persistent damage in intestinal cells rather than
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A measurable cellular defect could improve how doctors predict and prevent IBD relapses.
6:14 AMScienceDaily
Scientists solve a 50-year mystery and discover a new human blood group
Summary
Scientists identified the genetic cause of the AnWj blood group antigen, resolving a mystery first documented in 1972 and establishing the MAL blood group system. The finding should help laboratories identify rare AnWj-negative patients and donors and reduce the risk of dangerous transfusion reactions.
The discovery turns an obscure blood-group anomaly into a testable genetic condition. Blood banks can
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A genetic explanation gives clinicians a practical way to protect rare blood-group patients during transfusions.
Other Developments
A curated list of other prominent stories from this day.
A growing Bundibugyo virus outbreak is showing how a little-known Ebola relative can become a major threat when diagnosis and treatment options are limited. Experts warn that health systems focused on familiar pathogens may be unprepared for rare viruses that reemerge suddenly.
10:26 PMScienceDaily
Jehovah’s Witnesses have partly relaxed their longstanding prohibition on donated blood by allowing some blood-derived medical products. The ban on whole-blood transfusions remains in place.
10:13 AMStat News
Japan has more than 100,000 people aged 100 or older, reflecting the country’s rapid population ageing. Falling birth rates and worsening labour shortages are increasing pressure on its social care system.
12:31 AMAl Jazeera10:26 PMScienceDaily
A deadly ebola relative is surging after years in the shadows
Summary
A growing Bundibugyo virus outbreak is showing how a little-known Ebola relative can become a major threat when diagnosis and treatment options are limited. Experts warn that health systems focused on familiar pathogens may be unprepared for rare viruses that reemerge suddenly.
The outbreak exposes a preparedness gap: pathogens with limited surveillance, testing and treatment capacity can
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
A rare virus can become a major public-health threat when detection and response systems are built around more familiar pathogens.
10:13 AMStat News
Jehovah’s Witnesses allow blood-derived products but keep ban on whole-blood transfusions
Summary
Jehovah’s Witnesses have partly relaxed their longstanding prohibition on donated blood by allowing some blood-derived medical products. The ban on whole-blood transfusions remains in place.
The policy creates more room for individualized medical decisions while preserving the central prohibition on
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
The revised policy could change how clinicians plan blood-sparing care and obtain informed consent for Jehovah’s Witness patients.
12:31 AMAl Jazeera
Japan has record 100,000 people aged over 100: How societies are ageing
Summary
Japan has more than 100,000 people aged 100 or older, reflecting the country’s rapid population ageing. Falling birth rates and worsening labour shortages are increasing pressure on its social care system.
Japan’s demographic shift is now straining the workforce needed to support its oldest residents. The
Unlock the full First Pass Analysis to get a better understanding of why this story mattersWhy it matters
Japan’s care pressures show how longer lives become a systemic challenge when population decline shrinks the workforce supporting them.
Make it yours
Build Your First Pass.
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!